Work

Pegloticase causes prolonged improvement in multiple disease parameters in patients with chronic refractory gout who maintain low serum urate levels.

Year: 2022

Type: article

Source: PubMed

DOI: 10.55563/clinexprheumatol/3m095f

Authors: Robert T Keenan, Anthony E Yeo, Peter E Lipsky

Institutions: Duke University, Duke Medical Center, Ampel BioSolutions (United States)

Language: English

Topic: Gout, Hyperuricemia, Uric Acid

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4221158298

FWCI: 0.317

Cites:

Cited by: 2

Related to: 10